Kampmann Lab Featured in Vox Article on CRISPR Uses

Vox AD CRISPR Kampmann

 

The Kampmann Lab's approach of using CRISPR to identify relevant genes, mechanisms, and therapeutic targets in neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease was featured in a front page article on Vox. The article presents seven innovative ways in which CRISPR technology will make an impact in 2017.

Read the article...